You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FDG PET viability imaging

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiac FDG PET Viability Registry

Recruiting
  • Heart Failure
  • +2 more
    • Hamilton, Ontario, Canada
    • +3 more
    Jan 6, 2023

    Healthy Subjects, Cardiovascular Disease Trial (18F-FDG, 11C-butanol)

    Not yet recruiting
    • Healthy Subjects
    • Cardiovascular Disease
    • (no location specified)
    Aug 22, 2023

    Breast Cancer Female, Breast Cancer Recurrent Trial in Drammen (18F-FDG PET/CT)

    Recruiting
    • Breast Cancer Female
    • Breast Cancer Recurrent
    • 18F-FDG PET/CT
    • Drammen, Norway
      Drammen Hospital - Vestre Viken HF
    Feb 17, 2023

    Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

    Recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • Malignant Solid Neoplasm
    • Computed Tomography
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    May 3, 2023

    18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

    Completed
    • 18F-FAPI
    • +4 more
    • Hangzhou, Zhejiang, China
      the First Affiliated Hospital, School of Medicine, Zhejiang Univ
    May 31, 2023

    SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)

    Recruiting
    • SSTR2
    • +2 more
    • 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
    • Xiamen, Fujian, China
      The First Affiliated Hospital of Xiamen University
    May 24, 2023

    GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

    Enrolling by invitation
    • GEP-NET
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    Jan 24, 2023

    Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

    Not yet recruiting
    • Marginal Zone Lymphoma
    • (no location specified)
    Nov 6, 2023

    Lung Carcinoma Trial in Philadelphia (Fludeoxyglucose F-18, Positron Emission Tomography, Computed Tomography)

    Recruiting
    • Lung Carcinoma
    • Fludeoxyglucose F-18
    • +3 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Mar 7, 2023

    Glioma Trial in Portland (Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging)

    Not yet recruiting
    • Glioma
    • Fludeoxyglucose F-18
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jun 30, 2023

    Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)

    Recruiting
    • Rectal Cancer
    • Wuhan, Hubei, China
      China, Hubei Province
    Aug 11, 2023

    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

    Not yet recruiting
    • Anatomic Stage II Breast Cancer AJCC v8
    • +3 more
    • (no location specified)
    Jan 24, 2023

    Cervical Cancer Squamous Cell Trial in Toronto (18-FDG PET/CT, DWI, DCE-MRI)

    Completed
    • Cervical Cancer Squamous Cell
    • 18-FDG PET/CT, DWI, DCE-MRI
    • Toronto, Ontario, Canada
      University Health Network, The Princess Margaret
    Nov 7, 2022

    Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

    Not yet recruiting
    • Rectal Cancer
    • Chemoradiation treatment
    • 18FDG-PET/MRI scan
    • (no location specified)
    Sep 26, 2023

    Brain Glioblastoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging)

    Completed
    • Brain Glioblastoma
    • Computed Tomography
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    Simultaneous Fluorodeoxyglucose Positron Emission Tomography and

    Completed
    • Visual Snow Syndrome
    • simultaneous fluor-18 fluorodeoxyglucose (FDG) positron emission tomography with magnetic resonance imaging (PET/MRI)
    • (no location specified)
    Jan 26, 2023

    Lung Tumors, PET-CT Specimen Imager Trial in Ghent (AURA10 Specimen Imager)

    Not yet recruiting
    • Lung Neoplasms
    • PET-CT Specimen Imager
    • AURA10 Specimen Imager
    • Ghent, Belgium
      University Hospital Ghent
    Jan 11, 2023

    Multiple Myeloma Trial in Shenyang (18F-PSMA-1007, 18F-FDG)

    Recruiting
    • Multiple Myeloma
    • Shenyang, Liaoning, China
      The First Affiliated Hospital of China Medical University
    Jul 6, 2022

    Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)

    Recruiting
    • Tumor, Solid
    • Positron-Emission Tomography
    • 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
    • Xiamen, Fujian, China
      The First Affiliated Hospital of Xiamen University
    Sep 16, 2022

    Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

    Enrolling by invitation
    • Breast Cancer
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    Jan 18, 2023

    Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Bone Trial in Houston (Fludeoxyglucose F-18, Magnetic Resonance

    Active, not recruiting
    • Metastatic Malignant Neoplasm
    • Metastatic Malignant Neoplasm in the Bone
    • Fludeoxyglucose F-18
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    PET/MR for Characterization of Renal Masses (RMs)

    Recruiting
    • Renal Tumor
    • +2 more
    • 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Oct 5, 2023

    PET Brain Imaging in Chronic Cancer Pain

    Completed
    • Cancer Pain
      • Taipei City, Taiwan
        National Taiwan University Hosipital
      Sep 19, 2022

      Healthy Trial (Siemens Quadra PET/CT and [18F]FDG, Apple i-Watch)

      Not yet recruiting
      • Healthy
      • Siemens Quadra PET/CT and [18F]FDG
      • Apple i-Watch
      • (no location specified)
      Jun 30, 2023

      Breast Cancer Stage II, Breast Cancer Stage III, Solid Tumor Trial in Wuxi ([18F]SF-DEVD-2, [18F]-FDG)

      Recruiting
      • Breast Cancer Stage II
      • +2 more
      • Wuxi, Jiangsu, China
        Affiliated Hospital of Jiangnan University
      Apr 22, 2023